Literature DB >> 1507421

[Secondary sideroblastic anemia caused by long term administration of anti-tuberculous agents including isoniazid].

S Yoshimoto1, M Takeuchi, A Tada.   

Abstract

A 54 year-old man, who had been treated for several years with isoniazid, was transferred to our hospital because of intractable pulmonary tuberculosis. He was given several anti-tuberculous agents including INH, CS and/or PZA for a long period of time without improvement of the pulmonary tuberculosis. After 7 years' treatment with INH, hypochromic microcytic anemia developed. Parenteral administration of iron preparation failed to improve the anemia. The bone marrow findings revealed erythroid hyperplasia and a few erythroblasts showed megaloblastic change. The bone marrow iron staining revealed increased sideroblasts of which 88% were ringed-form. INH was then discontinued and pyridoxal phosphate was administered with rapid complete improvement of the anemia. INH is well known as a causative agent for acquired secondary sideroblastic anemia, however only one case of INH-induced sideroblastic anemia has been reported in Japan. This is the second reported Japanese case of INH-induced secondary sideroblastic anemia, which appears to be a very rare condition because of genetically determined rapid acetylation of INH in Japanese.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1507421

Source DB:  PubMed          Journal:  Rinsho Ketsueki        ISSN: 0485-1439


  2 in total

1.  Ameliorating role of caffeic acid phenethyl ester (CAPE) against isoniazid-induced oxidative damage in red blood cells.

Authors:  Osman Gokalp; Efkan Uz; Ekrem Cicek; H Ramazan Yilmaz; Mehmet Kaya Ozer; Ayse Altunbas; Nurten Ozcelik
Journal:  Mol Cell Biochem       Date:  2006-09-09       Impact factor: 3.396

2.  Severe isoniazid related sideroblastic anemia.

Authors:  Rein Jan Piso; Kveti Kriz; Marie-Claire Desax
Journal:  Hematol Rep       Date:  2011-01-21
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.